# WelChol® and Insulin in Treating Patients With Type 2 Diabetes

> **NCT00151749** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 260 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Colesevelam hydrochloride

## Key facts

- **NCT ID:** NCT00151749
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 260 (—)
- **Last updated:** 2012-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151749, "WelChol® and Insulin in Treating Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00151749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*